Cellspect Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 22, 2027The maintenance fee for Iron (II) ion detection agent and detection method using same (US 10,451,640) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
- 1 fee due Sep 17, 2027The maintenance fee for Data acquisition method for determining likelihood that ovarian endometriotic cyst is cancerous, and diagnostic device for same (US 10,591,483) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D877,925 | Analytical instrument In force · USPTO record | In force | USPTO record | |
| US D877,926 | Analytical instrument In force · USPTO record | In force | USPTO record | |
| US D878,619 | Analytical instrument In force · USPTO record | In force | USPTO record | |
| US 10,591,483 | Data acquisition method for determining likelihood that ovarian endometriotic cyst is cancerous, and diagnostic device for same In force · USPTO record | In force | USPTO record | |
| US 10,451,640 | Iron (II) ion detection agent and detection method using same In force · USPTO record | In force | USPTO record | |
| US 11,499,975 | Data acquisition method for determining likelihood that ovarian endometriotic cyst is cancerous, and diagnostic device for same In force · USPTO record | In force | USPTO record | |
| US D968,638 | Test chip In force · USPTO record | In force | USPTO record | |
| US D968,639 | Test chip In force · USPTO record | In force | USPTO record | |
| US D985,399 | Color matching card In force · USPTO record | In force | USPTO record | |
| US D986,072 | Color matching card In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 1 abandoned · 1 no status recorded
Showing 1 to 3 of 3, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/796,295 | Blood Test Device | Aug 7, 2024 | Pending |
| 17/963,719 | Hemoglobin Concentration Measuring System, Transvaginal Probe, Attachment, and Hemoglobin Concentration Measuring Method | Oct 11, 2022 | Abandoned |
| 16/339,031 | May 25, 2017 | No status recorded |